Ginsenoside Rg3 targets cancer stem cells and tumor angiogenesis to inhibit colorectal cancer progression in vivo.
- Resource Type
- Article
- Source
- International Journal of Oncology; Jan2018, Vol. 52 Issue 1, p127-138, 12p
- Subject
- Language
- ISSN
- 10196439